 
    Invemed Catalyst Fund, a New York-based private equity firm, specializes in buyouts and minority stakes in small-cap public companies.
Invemed Catalyst Fund, L.P. specializes in buyouts and minority stakes in small-cap public companies. It also sponsors corporate orphans and start-ups. The fund focuses its investments in retail, medical technology, and technology companies.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Oct 1, 2009
                      
                            Micell Technologies | Series B | $15M | Biotechnology | — | 
| 
                      Feb 26, 2008
                      
                            Proficiency | Series Unknown | $4.25M | Enterprise Software | — | 
| 
                      Jul 12, 2007
                      
                            Micell Technologies | Series A | $7M | Biotechnology | Yes | 
| 
                      Aug 5, 2004
                      
                            Kalypsys | Series B | $29M | Biotechnology | Yes | 
| 
                      Oct 1, 2003
                      
                            Reliant Pharmaceuticals | Series D | $115M | Biotechnology | Yes | 
Invemed Catalyst Fund has had 1 exits. Invemed Catalyst Fund most notable exits include Reliant Pharmaceuticals
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Nov 21, 2007 | Reliant Pharmaceuticals | M&A | Biotechnology | Detail |